EUVIMEDEUVIMED entdecken
Crossref

Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs)

Kalyani R Patel, Andres F Espinoza, Martin Urbicain, Roma H Patel, Angela Major, Stephen F Sarabia, Dolores Lopez-Terrada, Sanjeev A Vasudevan, Sarah E Woodfield

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Kalyani R Patel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Anatomic Pathology Division, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA. Elec…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit nennt 45 Literaturangaben. Gefördert von: CPRIT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in targeted therapies for pediatric hepatocellular tumors have been limited due to a paucity of clinically relevant models. Establishment and validation of intrahepatic patient-derived xenograft (PDX) models would help bridging this gap. The aim of this study is to compare the histomorphologic and immunophenotypic fidelity of patient tumors and their corresponding intrahepatic PDX models. Murine PDX models were established by intrahepatic implantation of patient tumors. Pathology slides from both patients and their corresponding PDX models were reviewed and quantitatively assessed for various histologic components and immunophenotypic markers. Ten PDX models were successfully established from nine patients with pre- (n=3) and post- (n=6) chemotherapy samples; diagnosed of hepatoblastoma (n=8) and hepatocellular neoplasm, not otherwise specified (n=1). Two of nine (22.2%) patients showed ≥75% fetal component; however, the corresponding PDX models did not maintain this fetal differentiation. High grade histology was seen in three patients (33.3%) and overrepresented in six PDX models (60%). Within the subset of three PDXs that were further characterized, significant IHC concordance was seen in all 3 models for CK7, CK19, Ki-67, and p53; and 2 of 3 models for Sox9 and Beta-catenin. GPC-3 and GS showed variable to moderate concordance, while Hepar was the least concordant. Our study shows that in general, the PDX models appear to represent the higher-grade component of the original tumor and show significant concordance for Ki-67, making them appropriate tools for testing new therapies for the most aggressive, therapy-resistant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChildHumansAnimalsMiceXenograft Model Antitumor AssaysHeterograftsKi-67 Antigen

Stichwörter der Autor:innen

HepatoblastomaHistopathologyImmunohistochemistryLiverPediatricXenograft

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

  • Department of Pathology and Immunology, Anatomic Pathology Division, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA. Electronic address: krpatel@texaschildrens.org.
  • Department of General Surgery, Division of Pediatric Surgery, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
  • Department of Pathology and Immunology, Genomic Medicine Division, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
  • Department of Pathology and Immunology, Anatomic Pathology Division, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.

Förderung

  • CPRIT

Zitieren

APA

Patel, K. R., Espinoza, A. F., Urbicain, M., Patel, R. H., Major, A., Sarabia, S. F., Lopez-Terrada, D., Vasudevan, S. A., & Woodfield, S. E. (2024). Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs). Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155163

Vancouver

Patel KR, Espinoza AF, Urbicain M, Patel RH, Major A, Sarabia SF, et al. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs). Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155163

BibTeX
@article{Patel2024,
  author = {Patel, Kalyani R and Espinoza, Andres F and Urbicain, Martin and Patel, Roma H and Major, Angela and Sarabia, Stephen F and Lopez-Terrada, Dolores and Vasudevan, Sanjeev A and Woodfield, Sarah E},
  title = {Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs)},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155163}
}
Kostenlos starten →